In January, a company you have probably never thought about hired two of the largest banks on Wall Street to explore selling itself, and the share price has spent every month since behaving like an ordinary Tuesday.
Most strategic reviews earn exactly that shrug, because they are usually stalling dressed up as strategy. Read on, and you will see why the names on this particular mandate change the odds considerably.

Free AI mapping (Sponsored)
SpaceX showed investors how fast an IPO window can disappear once trading begins.
Now another major AI filing is still sitting in the filed-but-not-priced stage — meaning the opening price has not been set yet.
Good Morning Alerts mapped out the public companies already tied to the business, plus 3 key suppliers supporting its compute, power, and distribution needs.
See the Stocks Positioned Before the Price Is Set

Retail
Academy Trades Near 7x Guided Earnings After Raising Its Cash-Flow Outlook

Academy Sports + Outdoors (NASDAQ: ASO) raised its earnings outlook after quarterly adjusted EPS increased 19.1% to $2.31 and sales grew 3%. Management now expects full-year adjusted EPS of $6.50 to $6.90, giving the sporting-goods retailer a fresh catalyst despite continued pressure on consumer spending.
At approximately $48, Academy trades near 7.2 times the midpoint of that guidance and 7.7 times guided GAAP earnings. Even after the earnings rally, the valuation suggests limited confidence in a sustained recovery.
Cash generation strengthens the case. Management raised adjusted free-cash-flow guidance to $300 million–$350 million, implying roughly a 10% to 12% yield against its approximately $3 billion market value. Academy also repurchased $182.1 million of shares during the first half.
Cash Generation Gives the Discount More Substance
The opportunity becomes more convincing when you pair the low earnings multiple with the improved cash-flow outlook. Delivering that cash would support further capital returns, while stabilizing existing-store demand would give the market a stronger reason to reconsider the valuation. Neither outcome requires a return to unusually strong consumer spending.
Buybacks Cannot Replace Stronger Store Sales
Comparable sales fell 0.4%, and quarterly earnings included a tariff-refund benefit. Full-year net-income guidance stayed unchanged, with a lower share count supporting the EPS upgrade. Your upside therefore depends on durable operating performance alongside repurchases, while continued demand weakness remains the clearest reason the discount persists.

Health
Herbalife’s $250 Million Buyback Puts Its Turnaround Story Back in Focus

Herbalife Ltd. (NYSE: HLF) authorized a $250 million share-repurchase program after reporting a fourth consecutive quarter of year-over-year sales growth. Management says the three-year authorization reflects confidence in the company’s cash generation and long-term strategy.
Herbalife trades near $12.25 with a market value of roughly $1.28 billion. Based on the company’s $670 million to $690 million adjusted EBITDA outlook and its approximately $3.12 billion enterprise value, the stock trades near 4.6 times guided EBITDA.
A buyback authorization worth nearly 20% of the equity value gives the market a fresh reason to revisit a company already trading at a low enterprise multiple. When returning sales growth is combined with lower financing costs and stronger cash generation, you get a value case that extends beyond a stock simply looking cheap.
Lower Interest Costs Improve the Cash-Flow Picture
Herbalife refinanced its debt in April, replacing 12.25% secured notes with longer-dated financing that included 7.75% notes. Management expects roughly $45 million in annual cash-interest savings, creating more room for debt reduction, share repurchases, and investment in its personalized nutrition strategy.
Debt and the Business Model Still Limit the Rerating
Debt remained above $2 billion at the end of June, adjusted EBITDA margin declined year over year, and China sales fell sharply. Regulatory scrutiny, foreign-exchange pressure, and distributor-retention risks remain central concerns, leaving your potential return tied to continued sales growth and management actually retiring shares at current prices.

Stay Ready (Sponsored)
The current economic chaos is just a preview…
What's coming next could be way scarier.
That's according to a strange investment secret - discovered just before the Great Depression…
And it's likely to catch most Americans by surprise.
If you're retired or planning to retire…
If you have any kind of money in the stock market…
Click here to learn more - before it's too late!
Learn How to Prepare

Consumer Staples
UNFI Trades Near 6x EBITDA After Generating a Decade-High $323 Million in Free Cash Flow

United Natural Foods, Inc. (NYSE: UNFI) reported fiscal Q4 results that showed adjusted EBITDA rising 48.3% for the quarter and 27% for the full year. Free cash flow reached $323 million, the company’s highest level in more than a decade.
Even after the earnings update, UNFI trades near $45 with a market value of roughly $2.7 billion. Based on fiscal 2027 adjusted EBITDA guidance of $730 million to $780 million and net debt of approximately $1.54 billion, the company trades near 5.6 times midpoint adjusted EBITDA.
Revenue declined during fiscal 2026 because of planned network optimization actions and the completion of temporary project work. Underlying sales excluding those effects grew at a low-single-digit rate, while debt fell by $295 million and a new $200 million buyback adds another potential source of per-share value. That combination gives you a case built on operating improvement rather than a cheap multiple alone.
The Cleanup Is Already Producing Better Cash Flow
UNFI’s fill rates, on-time deliveries, and distribution-center throughput improved for the fourth consecutive quarter. Management expects fiscal 2027 free cash flow of $275 million to $325 million, adjusted EBITDA growth in the high single digits, and a return to revenue growth as the optimization cycle passes.
Debt Still Keeps the Multiple Compressed
UNFI remains a low-margin distributor with meaningful leverage, and fiscal 2027 free cash flow guidance sits below the $323 million generated in the latest year. The rerating case requires execution across the supply chain, but your potential return is supported by falling debt, improving efficiency, and a valuation near six times EBITDA.

Actionable Picks This Week
LKQ Corporation (NASDAQ: LKQ)
In January, this company opened a formal review that includes selling itself outright, then hired Bank of America and Goldman Sachs to run it. The stock has behaved as though none of that happened. Fair enough; most reviews are management stalling with a press release, and fading them is usually correct.
But you do not put two banks of that size on one mandate to stage a beauty contest and then go home empty-handed. The gap between this price and what a strategic or private equity buyer could pay runs into the billions. Watch next earnings for confirmation that bids are in hand, and note that even a partial sale gets you most of the unlock.
Cooper Companies (NASDAQ: COO)
Contact lenses and fertility treatment were both meant to be reliable growth stories. Instead, they spent eighteen months eating currency headwinds, softer elective demand, and inventory clean-up in the specialty channel, and if you have held this, you felt all three. Here is what changed: those drags are annualizing out, so the comparisons stop working against the company.
Shares sit well under the most-followed fair value estimate, and that estimate assumes only modest margin recovery on a business that earns double-digit returns on capital when conditions are normal. Earnings land this week, so size before the print, not after.
Gentex (NASDAQ: GNTX)
This one is boring on purpose, and that is the entire appeal. Near monopoly on auto dimming mirrors, serious free cash flow, essentially no debt, which is a combination that rarely goes on sale for long.
Auto production has been the anchor, but the original equipment cycle looks to be bottoming, and the content-per-vehicle story around driver assistance systems is real rather than a slide in a pitch deck. The earnings multiple has been stuck in the low teens far longer than the quality justifies. When cycle sentiment turns, that stuck multiple is where the move comes from. Add into any tariff-driven weakness.

Free Weiss briefing (Sponsored)
Weiss Ratings has flagged early warning signs before major financial shifts for decades.
Now their research team is pointing to a new issue tied to retirement accounts.
They put together a short briefing explaining what's happening and why it matters.
See the full warning.

Fast Movers to Watch
Lincoln National (NYSE: LNC)
This is the insurance value trade everyone keeps stepping over. The reinsurance deal to derisk the legacy annuity book is largely finished, which was the one thing keeping serious buyers on the sidelines, and the balance sheet is materially cleaner for it.
The stock still trades at a low single-digit earnings multiple, so any credibility win on the next call moves it quickly.TEGNA (NYSE: TGNA)
TEGNA sits on durable retransmission cash flows while running an aggressive buyback, with persistent chatter about private equity or strategic interest since the Standard General deal collapsed.
The political advertising season is the near-term catalyst, and it arrives on a schedule nobody has to guess at. Local broadcast is deeply unfashionable, which is exactly why those cash flows are available at this price.Bank OZK (NASDAQ: OZK)
The market has spent two years flogging this bank over its commercial real estate book while it quietly posts sector-leading returns on equity at roughly eight times earnings.
High returns and low multiples do not normally coexist unless something is expected to break. If the Fed cuts and commercial real estate fears keep fading into 2027, that multiple comes back in a hurry.

How do you actually source your best investment ideas? Not how you should — how you actually do.
- Reading — annual reports, 10-Ks, trade publications. The ideas are in the documents most people won't sit through.
- Network — a small circle of people I trust who think differently than I do
- Screens — I start with quantitative filters and then do qualitative work on what passes
- Watching what insiders and smart money are doing — 13F filings, Form 4s, and a few managers I track closely

Everything Else
232 companies listed on U.S. exchanges through August, raising over $251 billion, but a strict liquidity and cash runway screen narrowed the entire class down to just 7 names.
Novartis tumbled 12% after Phase 3 results showed no significant improvement in patients treated for myotonic dystrophy type 1.
Lockheed Martin ticked higher after UBS upgraded the defense contractor to buy, citing underappreciated earnings growth potential.
Morgan Stanley named M&T Bank a top pick, upgrading to Overweight and lifting its target to $304 from $253.
The Dow tumbled 628 points for a second straight losing session as Middle East tensions escalated ahead of a key inflation reading.
West Texas Intermediate futures climbed for a sixth consecutive day, the longest rally since March, pushing oil closer to $100.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.
Best Regards,
—Noah Zelvis
Undervalued Edge




